clopidogrel

(MedPage Today) -- Compared with platelet reactivity to clopidogrel (Plavix), the measure of C-reactive protein (CRP) was a better predictor of adverse cardiovascular events in patients undergoing percutaneous coronary intervention (PCI), researchers reported.

(MedPage Today) -- The labeling on the proton-pump inhibitor dexlansoprazole (Dexilant) has been updated to reflect its compatibility with clopidogrel (Plavix), according to Takeda, the drug's maker.

SAN FRANCISCO (MedPage Today) -- The novel fast-acting IV antiplatlet drug cangrelor provided an effective bridge for patients on thienopyridine therapy, including clopidogrel (Plavix), who required bypass surgery, according to results of the late-breaking BRIDGE trial.

(McMaster University) New findings by McMaster University researchers contradict earlier reports that people with a certain genetic make-up don't benefit from the blood-thinner clopidogrel, also known as Plavix.

(MedPage Today) -- Almost 90% of percutaneous coronary intervention patients with an altered platelet reactivity genotype responded to tailored clopidogrel (Plavix) therapy, French investigators reported.

(Cardiovascular Research Foundation) Results from a late breaking clinical trial called COGENT demonstrate that the combination of giving patients clopidogrel, a blood thinner commonly prescribed to patients with cardiovascular disease, and stomach medicines such as omeprazole, known as proton pump inhibitors, did not lead to adverse events, as some prior studies had suggested.

The results were presented at the 21st annual Transcatheter Cardiovascular Therapeutics scientific symposium, sponsored by the Cardiovascular Research Foundation.

PARIS (MedPage Today) -- For the small percentage of MI patients younger than 45 who are homozygous for a certain gene variant, clopidogrel (Plavix) may be significantly less effective in secondary prevention, researchers reported here.

BOSTON -- Hemodialysis patients appear to derive no benefit in improving vascular access from clopidogrel (Plavix), a multicenter study showed.